Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gotthardt

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|May 11, 2016
Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation studyMartina Sterneck, Gernot M Kaiser, Nils Heyne, et al.
Hepatology (Baltimore, Md.)|September 11, 2008
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adultsDaniel Gotthardt, Heiko Runz, Verena Keitel, et al.
Nature Microbiology|January 24, 2017
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Nature Microbiology|December 20, 2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Plos One|October 22, 2015
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing CholangitisKornelius Schulze, Tobias J Weismüller, Michael Bubenheim, et al.
Gastroenterology|March 15, 2018
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in HepatocytesOliver Grünvogel, Ombretta Colasanti, Ji-Young Lee, et al.
Gut|July 14, 2016
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitisSebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|May 11, 2016
Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation studyMartina Sterneck, Gernot M Kaiser, Nils Heyne, et al.
Hepatology (Baltimore, Md.)|September 11, 2008
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adultsDaniel Gotthardt, Heiko Runz, Verena Keitel, et al.
Nature Microbiology|January 24, 2017
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Nature Microbiology|December 20, 2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Plos One|October 22, 2015
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing CholangitisKornelius Schulze, Tobias J Weismüller, Michael Bubenheim, et al.
Gastroenterology|March 15, 2018
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in HepatocytesOliver Grünvogel, Ombretta Colasanti, Ji-Young Lee, et al.
Gut|July 14, 2016
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitisSebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Pageof 6